Enabling Digitalization from R&D to Manufacturing - AI Ready Data through Ingestion & Standardization
Webinar Overview
Join us to explore the impact of digitalization and automation on R&D and manufacturing. This webinar will cover how advanced data capture and standardization techniques are creating AI-ready data, driving innovation in drug discovery, development and manufacturing.
The session will discuss how partnering with the biopharmaceutical industry can streamline the data lifecycle, from capture to standardization, ensuring data is AI-ready. By integrating diverse data sources and automating traditionally manual processes, efficiency is enhanced, and errors are reduced. This seamless data transfer between R&D and manufacturing accelerates the delivery of personalized medicines and reduces costs.
Discover how these solutions can revolutionize your digital transformation and optimize your R&D and manufacturing workflows.
November 20, 2024 | 11:00 a.m. EST
Speakers
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciY
Anna has a degree in Chemistry and a Ph.D. in Protein NMR from the University of Barcelona, Spain. She undertook her post-doc in protein NMR at the MRC Laboratory of Molecular Biology in Cambridge, UK, and following that worked in the Analytical R&D department of Pfizer for seven years, becoming proficient in low level impurity structure elucidation, reaction monitoring, qNMR and the preparation of regulatory documentation. She received a Pfizer Worldwide Achievement Award for the implementation of reaction monitoring by NMR in an open access environment.
She joined Bruker in 2011 and had different roles since including Material Characterisation Laboratory Manager, Product Portfolio Manager and for several years was in charge of driving the Biopharmaceutical business at Bruker BioSpin. Anna recently moved to SciY as Senior Director of Strategy and Business Development.